2 completed, 2 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
Follow Chuangzhen Chen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma Intestinal Low Dose Radiotherapy-1Gy, PD-1/PD-L1 inhibitors, Chemotherapy - Borderline Resectable Carcinoma, Unresectable Cancer | Phase 2 | Recruiting | Chuangzhen Chen | 39 | 2025-12-05 | 2026-10-05 |
| Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors Low-dose radiotherapy to the intestine (ILDR), PD-1/PD-L1 monoclonal antibodies - Radiotherapy, Metastatic Solid Cancers | Phase 2 | Recruiting | Chuangzhen Chen | 48 | 2025-09-26 | 2025-11-20 |
| Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors Intestinal Low Dose Radiotherapy-1Gy, PD-1/PD-L1 Inhibitors - Metastatic Malignant Solid Neoplasm, Radiotherapy | Phase 2 | Completed | Chuangzhen Chen | 24 | 2023-12-26 | 2026-07-30 |
| Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer SMART, PF - Esophageal Neoplasms | Phase 2 | Completed | Chuangzhen Chen | 85 | 2012-08-01 | 2022-01-03 |
Esophageal Neoplasms (2) · Esophageal Squamous Cell Carcinoma (2) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
Immune Checkpoint Inhibitors (2) · Cisplatin (1) · Drug Therapy (1) · Fluorouracil (1) · Surgical Procedures, Operative (1)
China (4)